Advances in the pathophysiology and treatment of anaemia in multiple myeloma
The use of the new immunotherapeutic drugs in multiple myeloma patients is associated with an increased incidence of anaemia that should be considered by clinicians particularly in the management of those patients in which coexist other anaemia-related factors.
Authors
- N. Giuliani
- Laura Notarfranchi (ORCID: https://orcid.org/0000-0002-4069-1323)
- Benedetta dalla Palma
Institutions
- University of Parma (IT)
- University Hospitals Parma Medical Center (US)
- Azienda Usl Toscana Centro (IT)
Publication Details
- Journal
- Current Opinion in Hematology
- Published
- 2026-02-11
- DOI
- https://doi.org/10.1097/moh.0000000000000911
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00